The vitiligo is an autoimmune disease characterised by the destruction of melanocytes, the cells responsible for producing melanin, thus leading to the depigmentation of certain areas of the body. Although genetic predispositions are largely involved in its development, several environmental factors may also promote the onset of vitiligo. Among these, sun exposure is cited as a potential trigger, due to the oxidative stress it can induce in melanocytes.
However, phototherapy is one of the most widely used approaches to promote repigmentation of vitiligo lesions.
PUVA phototherapy, combining psoralen and UVA rays, works by modulating the immune response, notably reducing the activity of T lymphocytes. In turn, narrowband UVB phototherapy (NB-UVB) stimulates the proliferation and migration of melanocytes still present in adjacent areas. However, uncontrolled sun exposure can cause sunburn or local inflammation, which may aggravate existing lesions, particularly through the Koebner phenomenon, where skin trauma triggers the appearance of new patches.
A study conducted on 442 vitiligo patients, distributed across different phototypes (I to VI), analysed their perception of solar risk. Among them, 86 patients stated that their patches appeared more visible after exposure, and 113 believed their depigmented areas were more vulnerable to sunburn. These observations reflect a common subjective experience among patients. Furthermore, they often consider that vitiligo increases the risk of developing melanoma.
Contrary to what one might expect, vitiligo appears to reduce cancer incidence, since the autoimmunity induced by vitiligo seems to confer protection against melanomas. Moreover, patients with vitiligo often have better reflexes for photoprotection.
Indeed, a large-scale 2014 study analysed a cohort of 10 040 patients with vitiligo to assess their risk of skin cancer compared with a control group. The findings revealed a markedly lower incidence of skin cancer in individuals with vitiligo. However, the study also identified an increased risk of cutaneous cancers in patients who had undergone phototherapy sessions (14.1% versus 3.2%).